Skip to content
Sectors How it works Pricing Client stories

Insights

Companies Live signals Events Markets Trends Company lists
Log in
Platform Signal Tracker API Radar Book a 7-day Readout
General Biosystems, Inc logo — Innovative biotechnology driving high-throughput, automated...

General Biosystems, Inc

Innovative biotechnology driving high-throughput, automated DNA construct production to create blueprints for new and enhanced biological functions.

Founded 2013 United States Morrisville, United States 4 employees Venture round Biotechnology

General Information

Company Name General Biosystems, Inc
Founded Year 2013
Location United States Morrisville, United States
Employees 4
Industries Biotechnology
Funding Stage Venture round
Social

BounceWatch is an independent company data service, not affiliated with General Biosystems, Inc. To contact General Biosystems, Inc, visit generalbiosystems.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does General Biosystems, Inc compare?

A PDF of General Biosystems, Inc and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting General Biosystems, Inc soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About General Biosystems, Inc

General Biosystems, Inc. is a **biotechnology** company founded in **2012** and headquartered in the **United States**. The company's slogan, "Innovative biotechnology driving high-throughput, automated DNA construct production to create blueprints for new and enhanced biological functions," reflects their dedication to advancing the field. Through high-throughput, automated systems, General Biosystems produces high-quality **DNA constructs** driven by a deep understanding of genetic information storage and programming within DNA. Their innovative approach involves programming and physically writing or printing new genetic codes, thereby creating blueprints for new or enhanced biological functions. In their most recent funding round on **17 May 2021**, the company received investment from **LYFE Capital, Yida China Holdings, JinHe Ziben, Qingdao Chuyao Huayi Venture Capital Fund Partnership**, and **Ancheng Capital**, signifying the high level of interest and confidence from notable investors in General Biosystems' innovative biotechnology endeavors.

Business keywords: DNA Synthesis, Gene Synthesis, Molecular Biology, Biosystem Optimization, Protein Expression, High-throughput, Automated Production, Genetic Codes, Innovative Technologies, Bioinformatics, Genetic Information, DNA Constructs, Biological Functions, Genetic Programming

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Venture Round Undisclosed 5
LYFE Capital
LYFE Capital, Yida China Holdings +3
17 May 2021

General Biosystems, Inc Alternatives & Competitors

View All Alternatives
General Biosystems, Inc vs
DNA2.0 (now ATUM)
DNA2.0 (now ATUM) United States

This page is retired. You can find our new company page at www.linkedin.com/company/atum-bio

9 employees
Biotechnology
General Biosystems, Inc vs
SynHelix
SynHelix France

Demand for synthetic DNA is growing rapidly in biotech industry, and SynHelix aims to meet supply ne...

11-50 employees
Biotechnology
General Biosystems, Inc vs
Synbio Technologies
Synbio Technologies United States

Changing the world, one sequence at a time.

25 employees
Biotechnology, Health Care
Also compare with: General Biosystems, Inc vs Telesis Bio Telesis Bio View all alternatives

FAQ About General Biosystems, Inc

Innovative biotechnology driving high-throughput, automated DNA construct production to create blueprints for new and enhanced biological functions.
General Biosystems, Inc was founded in 2013.
General Biosystems, Inc is headquartered in Morrisville, United States.
General Biosystems, Inc operates in Biotechnology. Its work centres on DNA Synthesis, Gene Synthesis, Molecular Biology and Biosystem Optimization.
General Biosystems, Inc has approximately 4 employees.
General Biosystems, Inc has completed 1 funding round. The latest funding stage is Venture round.
Top alternatives and competitors to General Biosystems, Inc include DNA2.0 (now ATUM), SynHelix, Synbio Technologies, Evonetix Ltd, Arbor Biotechnologies. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
General Biosystems, Inc and DNA2.0 (now ATUM) are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for General Biosystems, Inc, https://bouncewatch.com/company/general-biosystems-inc, updated 25 October 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout